ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	23/235	191/7206	4.83973020648e-08
ko00643	Styrene degradation	4/235	4/7206	1.10334736898e-06
ko04512	ECM-receptor interaction	13/235	79/7206	1.320641693e-06
ko00350	Tyrosine metabolism	7/235	33/7206	7.42025223483e-05
ko04974	Protein digestion and absorption	10/235	96/7206	0.00108264746109
ko05410	Hypertrophic cardiomyopathy (HCM)	10/235	100/7206	0.00148308107061
ko00140	Steroid hormone biosynthesis	6/235	41/7206	0.00194786685803
ko04510	Focal adhesion	17/235	240/7206	0.00239766512157
ko05414	Dilated cardiomyopathy	10/235	112/7206	0.0034512238269
ko00120	Primary bile acid biosynthesis	4/235	20/7206	0.00353809717765
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/235	79/7206	0.00402637372129
ko04640	Hematopoietic cell lineage	7/235	64/7206	0.00457859984776
ko05146	Amoebiasis	9/235	99/7206	0.00482869857219
ko05034	Alcoholism	1/235	238/7206	0.00495565209525
ko05206	MicroRNAs in cancer	13/235	177/7206	0.00769077165631
ko05203	Viral carcinogenesis	2/235	277/7206	0.00890448852126
ko05016	Huntington's disease	1/235	215/7206	0.0104489445123
ko00565	Ether lipid metabolism	5/235	42/7206	0.0112416462095
ko04064	NF-kappa B signaling pathway	8/235	96/7206	0.0127784624625
ko04976	Bile secretion	7/235	80/7206	0.0151191992122
ko05222	Small cell lung cancer	7/235	89/7206	0.0256858743356
ko04151	PI3K-Akt signaling pathway	21/235	390/7206	0.0261265268955
ko00401	Novobiocin biosynthesis	1/235	1/7206	0.0326117124619
ko04020	Calcium signaling pathway	15/235	265/7206	0.0330832767286
ko04658	Th1 and Th2 cell differentiation	7/235	96/7206	0.0367780185007
ko02010	ABC transporters	4/235	39/7206	0.0371478010776
ko04630	Jak-STAT signaling pathway	9/235	132/7206	0.0402815798023
ko04931	Insulin resistance	9/235	137/7206	0.0448868480807
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/235	11/7206	0.0479779311798